SAN DIEGO, March 16, 2022 /PRNewswire/ -- Cue Health ("Cue") (Nasdaq: HLTH), the healthcare technology company behind the most accurate at-home COVID-19 test* in the U.S., today announced that its ...

In case you missed it, this commercial for Cue COVID tests made its debut during the Super Bowl. Cue lab-quality COVID-19 tests are at-home, molecular tests that need no prescription or special ...

The global diagnostics market was valued at approximately $180 billion in 2022 and is projected to grow to over $348 billion by 2030. Some of the key drivers of that growth are molecular diagnostics ...

San Diego, California-based Cue, not to be confused with fertility tracker company Clue, raised $7.5 million in a round led by SherpaVentures with participation from existing investor Immortalana.

In largest-of-its-kind clinical study on asymptomatic people, Cue demonstrated 99.4% accuracy compared to lab-based PCR SAN DIEGO, Calif., Aug. 17, 2022 /PRNewswire/ -- Cue Health Inc. ("Cue") (Nasdaq ...

A few weeks ago, when we revisited Eric Topol's top 10 digital health predictions, Topol mentioned microfluidics -- and the ability to create home versions of medical lab tests -- as one of the ...